Contact
Please use this form to send email to PR contact of this press release:
MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Amyotrophic Lateral Sclerosis
TO:
Please use this form to send email to PR contact of this press release:
MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Amyotrophic Lateral Sclerosis
TO: